Cytel autoimmune/inflammation, cancer, infectious diseases/aids news

CYTL will spin off its vaccine program, contributing technology and transferring 25-30 employees to the new company. The entity will continue CYTL's programs

Read the full 236 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE